These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 35225130)

  • 41. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.
    Corti C; Antonarelli G; Scotté F; Spano JP; Barrière J; Michot JM; André F; Curigliano G
    Ann Oncol; 2022 Feb; 33(2):158-168. PubMed ID: 34718117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients.
    Broseta JJ; Rodríguez-Espinosa D; Soruco E; Maduell F
    Nephrol Dial Transplant; 2021 Aug; 36(9):1754-1755. PubMed ID: 34450648
    [No Abstract]   [Full Text] [Related]  

  • 43. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.
    Wierda WG; Zelenetz AD; Gordon LI; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Byrd JC; Caimi P; Fayad LE; Fisher RI; Glenn MJ; Habermann TM; Harris NL; Hernandez-Ilizaliturri F; Hoppe RT; Horwitz SM; Kaminski MS; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Martin MG; Nademanee A; Porcu P; Press O; Rabinovitch R; Reddy N; Reid E; Roberts K; Saad AA; Snyder ED; Sokol L; Swinnen LJ; Vose JM; Yahalom J; Dwyer MA; Sundar H
    J Natl Compr Canc Netw; 2017 Mar; 15(3):293-311. PubMed ID: 28275031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    Larkin HD
    JAMA; 2022 Jun; 327(23):2280. PubMed ID: 35727270
    [No Abstract]   [Full Text] [Related]  

  • 46. A booster with SARS-CoV-2 vaccines: protection against Omicron infection.
    Hu Y; Sun Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):115. PubMed ID: 35383164
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    Abbasi J
    JAMA; 2022 Jul; 328(2):120-121. PubMed ID: 35731542
    [No Abstract]   [Full Text] [Related]  

  • 48. T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.
    Marasco V; Carniti C; Guidetti A; Farina L; Magni M; Miceli R; Calabretta L; Verderio P; Ljevar S; Serpenti F; Morelli D; Apolone G; Ippolito G; Agrati C; Corradini P
    Br J Haematol; 2022 Feb; 196(3):548-558. PubMed ID: 34649298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety.
    Javadinia SA; Alizadeh K; Mojadadi MS; Nikbakht F; Dashti F; Joudi M; Harati H; Welsh JS; Farahmand SA; Attarian F
    Front Endocrinol (Lausanne); 2022; 13():860238. PubMed ID: 35586627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications.
    Levit E; Longbrake EE; Stoll SS
    Mult Scler Relat Disord; 2022 Apr; 60():103719. PubMed ID: 35276450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies.
    Maglione A; Morra M; Meroni R; Matta M; Clerico M; Rolla S
    Mult Scler Relat Disord; 2022 May; 61():103776. PubMed ID: 35364386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination.
    Inaba T; Okumura K; Maekura C; Muramatsu A; Kobayashi T; Kuroda J; Nukui Y
    Int J Hematol; 2022 Jun; 115(6):913-914. PubMed ID: 35412265
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.
    Bird S; Panopoulou A; Shea RL; Tsui M; Saso R; Sud A; West S; Smith K; Barwood J; Kaczmarek E; Panlaqui C; Kaiser M; Stern S; Pawlyn C; Boyd K
    Lancet Haematol; 2021 Jun; 8(6):e389-e392. PubMed ID: 33887255
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
    Tees MT; Flinn IW
    Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The DiaCoVAb Study in South Italy: Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients.
    Fucci A; Giacobbe S; Guerriero I; Suzumoto Y; D'Andrea EL; Scrima M; Nolli ML; Iervolino A; Chiuchiolo LA; Salvatore E; Renzulli R; La Peccerella L; Marra G; Liuzzi M; Santoro D; Zulli E; Gentile R; Clemente G; Capasso G
    Kidney Blood Press Res; 2022; 47(7):467-474. PubMed ID: 35318291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [COVID-19 Vaccines for Patients with Neurological Diseases].
    Nakajima H
    Brain Nerve; 2022 Jul; 74(7):893-898. PubMed ID: 35860937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Composite Lymphoma as Co-occurrence of Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Carrying Trisomy 12 and t(14;18) and Peripheral T-cell Lymphoma.
    Aoyama Y; Kodaka T; Zushi Y; Goto Y; Tsunemine H; Itoh T; Takahashi T
    J Clin Exp Hematop; 2018 Mar; 58(1):27-31. PubMed ID: 29415977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment.
    Jovicevic V; Ivanovic J; Momcilovic N; Andabaka M; Tamas O; Veselinovic N; Cujic D; Gnjatovic M; Mesaros S; Pekmezovic T; Drulovic J
    Mult Scler Relat Disord; 2022 Jun; 62():103794. PubMed ID: 35421782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab.
    Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Jahrsdörfer B; Schrezenmeier H; Ludwig C; Sattler A; Kotsch K; Chen Y; Claußnitzer A; Haibel H; Proft F; Guerra G; Durek P; Heinrich F; Ferreira-Gomes M; Burmester GR; Radbruch A; Mashreghi MF; Lino AC; Dörner T
    Arthritis Rheumatol; 2022 Jun; 74(6):934-947. PubMed ID: 34962360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.